##gff-version 3
##sequence-region Q16665 1 826
Q16665	UniProtKB	Chain	1	826	.	.	.	ID=PRO_0000127220;Note=Hypoxia-inducible factor 1-alpha	
Q16665	UniProtKB	Domain	17	70	.	.	.	Note=bHLH;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00981	
Q16665	UniProtKB	Domain	85	158	.	.	.	Note=PAS 1;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00140	
Q16665	UniProtKB	Domain	228	298	.	.	.	Note=PAS 2;Ontology_term=ECO:0000255;evidence=ECO:0000255|PROSITE-ProRule:PRU00140	
Q16665	UniProtKB	Domain	302	345	.	.	.	Note=PAC	
Q16665	UniProtKB	Region	1	401	.	.	.	Note=Interaction with TSGA10;Ontology_term=ECO:0000250;evidence=ECO:0000250	
Q16665	UniProtKB	Region	21	30	.	.	.	Note=DNA-binding;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q61221	
Q16665	UniProtKB	Region	170	191	.	.	.	Note=Required for heterodimer formation with ARNT;Ontology_term=ECO:0000250;evidence=ECO:0000250|UniProtKB:Q61221	
Q16665	UniProtKB	Region	380	417	.	.	.	Note=N-terminal VHL recognition site	
Q16665	UniProtKB	Region	401	603	.	.	.	Note=ODD	
Q16665	UniProtKB	Region	531	575	.	.	.	Note=NTAD	
Q16665	UniProtKB	Region	556	572	.	.	.	Note=C-terminal VHL recognition site	
Q16665	UniProtKB	Region	576	785	.	.	.	Note=ID	
Q16665	UniProtKB	Region	786	826	.	.	.	Note=CTAD	
Q16665	UniProtKB	Motif	718	721	.	.	.	Note=Nuclear localization signal;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q16665	UniProtKB	Compositional bias	615	621	.	.	.	Note=Poly-Thr	
Q16665	UniProtKB	Modified residue	247	247	.	.	.	Note=Phosphoserine%3B by CK1;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20699359;Dbxref=PMID:20699359	
Q16665	UniProtKB	Modified residue	402	402	.	.	.	Note=4-hydroxyproline;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11566883;Dbxref=PMID:11566883	
Q16665	UniProtKB	Modified residue	532	532	.	.	.	Note=N6-acetyllysine;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24681946;Dbxref=PMID:24681946	
Q16665	UniProtKB	Modified residue	551	551	.	.	.	Note=Phosphoserine%3B by GSK3-beta;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20889502;Dbxref=PMID:20889502	
Q16665	UniProtKB	Modified residue	555	555	.	.	.	Note=Phosphothreonine%3B by GSK3-beta;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20889502;Dbxref=PMID:20889502	
Q16665	UniProtKB	Modified residue	564	564	.	.	.	Note=4-hydroxyproline;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11292861,ECO:0000269|PubMed:11566883,ECO:0000269|PubMed:12351678,ECO:0000269|PubMed:25974097;Dbxref=PMID:11292861,PMID:11566883,PMID:12351678,PMID:25974097	
Q16665	UniProtKB	Modified residue	576	576	.	.	.	Note=Phosphoserine%3B by PLK3;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20889502;Dbxref=PMID:20889502	
Q16665	UniProtKB	Modified residue	589	589	.	.	.	Note=Phosphoserine%3B by GSK3-beta;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20889502;Dbxref=PMID:20889502	
Q16665	UniProtKB	Modified residue	657	657	.	.	.	Note=Phosphoserine%3B by PLK3;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20889502;Dbxref=PMID:20889502	
Q16665	UniProtKB	Modified residue	709	709	.	.	.	Note=N6-acetyllysine;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24681946;Dbxref=PMID:24681946	
Q16665	UniProtKB	Modified residue	800	800	.	.	.	Note=S-nitrosocysteine;Ontology_term=ECO:0000305;evidence=ECO:0000305|PubMed:12914934;Dbxref=PMID:12914934	
Q16665	UniProtKB	Modified residue	803	803	.	.	.	Note=(3S)-3-hydroxyasparagine;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12080085;Dbxref=PMID:12080085	
Q16665	UniProtKB	Cross-link	391	391	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO);Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:15465032,ECO:0000269|PubMed:17610843;Dbxref=PMID:15465032,PMID:17610843	
Q16665	UniProtKB	Cross-link	477	477	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in SUMO);Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:15465032,ECO:0000269|PubMed:17610843;Dbxref=PMID:15465032,PMID:17610843	
Q16665	UniProtKB	Cross-link	532	532	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin);Ontology_term=ECO:0000305;evidence=ECO:0000305|PubMed:16862177;Dbxref=PMID:16862177	
Q16665	UniProtKB	Cross-link	538	538	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin);Ontology_term=ECO:0000305;evidence=ECO:0000305|PubMed:16862177;Dbxref=PMID:16862177	
Q16665	UniProtKB	Cross-link	547	547	.	.	.	Note=Glycyl lysine isopeptide (Lys-Gly) (interchain with G-Cter in ubiquitin);Ontology_term=ECO:0000305;evidence=ECO:0000305|PubMed:16862177;Dbxref=PMID:16862177	
Q16665	UniProtKB	Alternative sequence	1	12	.	.	.	ID=VSP_044942;Note=In isoform 3. MEGAGGANDKKK->MSSQCRSLENKFVFLKEGLGNSKPEELEEIRIENGR;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:18638657;Dbxref=PMID:18638657	
Q16665	UniProtKB	Alternative sequence	735	735	.	.	.	ID=VSP_047335;Note=In isoform 2. G->I;Ontology_term=ECO:0000303;evidence=ECO:0000303|Ref.7	
Q16665	UniProtKB	Alternative sequence	736	826	.	.	.	ID=VSP_007738;Note=In isoform 2. Missing;Ontology_term=ECO:0000303;evidence=ECO:0000303|Ref.7	
Q16665	UniProtKB	Natural variant	582	582	.	.	.	ID=VAR_049541;Note=P->S;Dbxref=dbSNP:rs11549465	
Q16665	UniProtKB	Natural variant	588	588	.	.	.	ID=VAR_049542;Note=A->T;Dbxref=dbSNP:rs11549467	
Q16665	UniProtKB	Natural variant	796	796	.	.	.	ID=VAR_015854;Note=T->A;Dbxref=dbSNP:rs1802821	
Q16665	UniProtKB	Mutagenesis	247	247	.	.	.	Note=Constitutive kinase activity. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20699359;Dbxref=PMID:20699359	
Q16665	UniProtKB	Mutagenesis	247	247	.	.	.	Note=Impaired kinase activity. S->D;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20699359;Dbxref=PMID:20699359	
Q16665	UniProtKB	Mutagenesis	377	377	.	.	.	Note=No change in HIF1A protein turnover rate but increased transcriptional activity%3B when associated with R-391%3B R-477 and R-532. K->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:17610843;Dbxref=PMID:17610843	
Q16665	UniProtKB	Mutagenesis	389	389	.	.	.	Note=No change in sumoylation. K->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15465032;Dbxref=PMID:15465032	
Q16665	UniProtKB	Mutagenesis	391	391	.	.	.	Note=Abolishes 1 sumoylation. Abolishes 1 sumoylation%3B when associated with R-532. Abolishes 2 sumoylations%3B when associated with R-477. No change in HIF1A protein turnover rate but increased transcriptional activity%3B when associated with R-377%3B R-477 and R-532. K->R;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:15465032,ECO:0000269|PubMed:17610843;Dbxref=PMID:15465032,PMID:17610843	
Q16665	UniProtKB	Mutagenesis	392	392	.	.	.	Note=No change in sumoylation. K->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15465032;Dbxref=PMID:15465032	
Q16665	UniProtKB	Mutagenesis	394	394	.	.	.	Note=No change in VHLE3-dependent ubiquitination. P->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11566883;Dbxref=PMID:11566883	
Q16665	UniProtKB	Mutagenesis	397	397	.	.	.	Note=Abolishes VHLE3-dependent ubiquitination%3B when associated with A-400. L->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11566883;Dbxref=PMID:11566883	
Q16665	UniProtKB	Mutagenesis	400	400	.	.	.	Note=Abolishes VHLE3-dependent ubiquitination%3B when associated with A-397. L->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:11566883;Dbxref=PMID:11566883	
Q16665	UniProtKB	Mutagenesis	402	402	.	.	.	Note=Abolishes in VHLE3-dependent ubiquitination%2C abolishes oxygen-dependent regulation of VP16%2C partially reduced VHLE target site ubiquitination and no interaction with VHL. No VHLE target site ubiquitination%3B when associated with G-564. Increases HIF1A instability and reduces HIF1A-induced target gene transcriptional activation%3B when associated with A-564. P->A;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11566883,ECO:0000269|PubMed:16862177,ECO:0000269|PubMed:24681946;Dbxref=PMID:11566883,PMID:16862177,PMID:24681946	
Q16665	UniProtKB	Mutagenesis	442	442	.	.	.	Note=No change in sumoylation. K->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15465032;Dbxref=PMID:15465032	
Q16665	UniProtKB	Mutagenesis	460	460	.	.	.	Note=No change in sumoylation nor in ARD1-mediated acetylation. K->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:15465032;Dbxref=PMID:15465032	
Q16665	UniProtKB	Mutagenesis	477	477	.	.	.	Note=Abolishes 1 sumoylation. Abolishes 2 sumoylations%3B when associated with R-391. No change in HIF1A protein turnover rate but increased transcriptional activity%3B when associated with R-377%3B R-391 and R-532. K->R;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:15465032,ECO:0000269|PubMed:17610843;Dbxref=PMID:15465032,PMID:17610843	
Q16665	UniProtKB	Mutagenesis	532	532	.	.	.	Note=Reduced ubiquitination. No change in sumoylation nor on interaction with ARD1A. No change in HIF1A protein turnover rate but increased transcriptional activity%3B when associated with R-377%3B R-391 and R-477. Complete loss of ubiquitination%2C but no change in VHL binding%3B when associated with K-538 and K-547. K->R;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10944113,ECO:0000269|PubMed:15465032,ECO:0000269|PubMed:16288748,ECO:0000269|PubMed:16862177,ECO:0000269|PubMed:17610843;Dbxref=PMID:10944113,PMID:15465032,PMID:16288748,PMID:16862177,PMID:17610843	
Q16665	UniProtKB	Mutagenesis	538	538	.	.	.	Note=No change in sumoylation%2C but reduced ubiquitination. Complete loss of ubiquitination%2C but no change in VHL binding%3B when associated with K-532 and K-547. K->R;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10944113,ECO:0000269|PubMed:15465032,ECO:0000269|PubMed:16862177;Dbxref=PMID:10944113,PMID:15465032,PMID:16862177	
Q16665	UniProtKB	Mutagenesis	547	547	.	.	.	Note=No change in sumoylation%2C but reduced ubiquitination. Complete loss of ubiquitination%2C but no change in VHL binding%3B when associated with K-532 and K-538. K->R;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10944113,ECO:0000269|PubMed:15465032,ECO:0000269|PubMed:16862177;Dbxref=PMID:10944113,PMID:15465032,PMID:16862177	
Q16665	UniProtKB	Mutagenesis	551	551	.	.	.	Note=Constitutive expression under nonhypoxic conditions by decreasing ubiquitination. S->G;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10758161;Dbxref=PMID:10758161	
Q16665	UniProtKB	Mutagenesis	552	552	.	.	.	Note=Constitutive expression under nonhypoxic conditions by decreasing ubiquitination. T->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:10758161;Dbxref=PMID:10758161	
Q16665	UniProtKB	Mutagenesis	564	564	.	.	.	Note=Increases HIF1A instability and reduces HIF1A-induced target gene transcriptional activation%3B when associated with A-402. P->A;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11566883,ECO:0000269|PubMed:16862177,ECO:0000269|PubMed:24681946;Dbxref=PMID:11566883,PMID:16862177,PMID:24681946	
Q16665	UniProtKB	Mutagenesis	564	564	.	.	.	Note=No change in VHL-dependent ubiquitination. Partially reduced VHLE target site ubiquitination. No VHLE target site ubiquitination%3B when associated with A-402. P->G;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:11566883,ECO:0000269|PubMed:16862177,ECO:0000269|PubMed:24681946;Dbxref=PMID:11566883,PMID:16862177,PMID:24681946	
Q16665	UniProtKB	Mutagenesis	576	576	.	.	.	Note=Induces stabilization of the protein. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20889502;Dbxref=PMID:20889502	
Q16665	UniProtKB	Mutagenesis	657	657	.	.	.	Note=Induces stabilization of the protein. S->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:20889502;Dbxref=PMID:20889502	
Q16665	UniProtKB	Mutagenesis	709	709	.	.	.	Note=Abolishes SIRT2-mediated deacetylation%2C increases HIF1A instability and reduces HIF1A-induced target gene transcriptional activation. Increases interaction with EGLN1. K->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24681946;Dbxref=PMID:24681946	
Q16665	UniProtKB	Mutagenesis	719	719	.	.	.	Note=Dramatic reduction of accumulation in the nucleus in response to hypoxia. K->T;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10944113,ECO:0000269|PubMed:9822602;Dbxref=PMID:10944113,PMID:9822602	
Q16665	UniProtKB	Mutagenesis	795	795	.	.	.	Note=Inhibits interaction with EP300 and transactivation activity. L->A;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:12778114;Dbxref=PMID:12778114	
Q16665	UniProtKB	Mutagenesis	800	800	.	.	.	Note=Blocks increase in transcriptional activation caused by nitrosylation. C->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10202154,ECO:0000269|PubMed:12914934;Dbxref=PMID:10202154,PMID:12914934	
Q16665	UniProtKB	Mutagenesis	800	800	.	.	.	Note=Abolishes hypoxia-inducible transcriptional activation of ctaD. C->S;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:10202154,ECO:0000269|PubMed:12914934;Dbxref=PMID:10202154,PMID:12914934	
Q16665	UniProtKB	Mutagenesis	803	803	.	.	.	Note=Recruits CREBBP. No enhancement of CREBBP by Clioquinol in the presence of FIH1. No change in nuclear location nor on repression of transcriptional activity in the presence of histone deacetylase inhibitor. N->A;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:16543236,ECO:0000269|PubMed:16973622;Dbxref=PMID:16543236,PMID:16973622	
Q16665	UniProtKB	Sequence conflict	572	572	.	.	.	Note=F->L;Ontology_term=ECO:0000305;evidence=ECO:0000305	
Q16665	UniProtKB	Beta strand	241	246	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4H6J	
Q16665	UniProtKB	Beta strand	251	255	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4H6J	
Q16665	UniProtKB	Helix	258	263	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4H6J	
Q16665	UniProtKB	Helix	267	270	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4H6J	
Q16665	UniProtKB	Helix	275	277	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4H6J	
Q16665	UniProtKB	Turn	281	283	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4H6J	
Q16665	UniProtKB	Helix	284	297	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4H6J	
Q16665	UniProtKB	Beta strand	298	301	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4H6J	
Q16665	UniProtKB	Beta strand	305	308	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4H6J	
Q16665	UniProtKB	Beta strand	310	325	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4H6J	
Q16665	UniProtKB	Turn	327	329	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4H6J	
Q16665	UniProtKB	Beta strand	332	341	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:4H6J	
Q16665	UniProtKB	Helix	397	400	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5L9V	
Q16665	UniProtKB	Beta strand	408	410	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5LA9	
Q16665	UniProtKB	Helix	559	562	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:5L9B	
Q16665	UniProtKB	Turn	779	783	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1L8C	
Q16665	UniProtKB	Helix	784	787	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1L8C	
Q16665	UniProtKB	Beta strand	789	792	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1L8C	
Q16665	UniProtKB	Helix	797	803	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1L3E	
Q16665	UniProtKB	Beta strand	807	809	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1L8C	
Q16665	UniProtKB	Helix	815	822	.	.	.	Ontology_term=ECO:0000244;evidence=ECO:0000244|PDB:1H2K	
